Literature DB >> 25787090

Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia.

Ryoko Takeuchi1,2, Yasuko Toyoshima1, Mari Tada1, Hidetomo Tanaka1, Hiroshi Shimizu1, Atsushi Shiga3, Takeshi Miura4, Kenju Aoki4, Akane Aikawa5, Shin Ishizawa5, Takeshi Ikeuchi6, Masatoyo Nishizawa2, Akiyoshi Kakita1, Hitoshi Takahashi1.   

Abstract

Amyotrophic lateral sclerosis (ALS) may be accompanied by frontotemporal dementia (FTD). We report a case of glial mixed tau and TDP-43 proteinopathies in a Japanese patient diagnosed clinically as having ALS-D. Autopsy revealed loss of lower motor neurons and degeneration of the pyramidal tracts in the spinal cord and brain stem. The brain showed frontotemporal lobar degeneration (FTLD), the most severe neuronal loss and gliosis being evident in the precentral gyrus. Although less severe, such changes were also observed in other brain regions, including the basal ganglia and substantia nigra. AT8 immunostaining revealed that predominant occurrence of astrocytic tau lesions termed globular astrocytic inclusions (GAIs) was a feature of the affected regions. These GAIs were Gallyas-Braak negative. Neuronal and oligodendrocytic tau lesions were comparatively scarce. pS409/410 immunostaining also revealed similar neuronal and glial TDP-43 lesions. Interestingly, occasional co-localization of tau and TDP-43 was evident in the GAIs. Immunoblot analyses revealed band patterns characteristic of a 4-repeat (4R) tauopathy, corticobasal degeneration and a TDP-43 proteinopathy, ALS/FTLD-TDP Type B. No mutations were found in the MAPT or TDP-43 genes. We consider that this patient harbored a distinct, sporadic globular glial mixed 4R tau and TDP-43 proteinopathy associated with motor neuron disease and FTD.
© 2015 International Society of Neuropathology.

Entities:  

Keywords:  TDP-43; amyotrophic lateral sclerosis; astrocyte; frontotemporal lobar degeneration; motor neuron disease; tau

Mesh:

Substances:

Year:  2015        PMID: 25787090     DOI: 10.1111/bpa.12262

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  12 in total

1.  Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Authors:  Claire H Stevens; Natalie J Guthrie; Marloes van Roijen; Glenda M Halliday; Lezanne Ooi
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

2.  Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.

Authors:  P Tacik; M Sanchez-Contreras; M DeTure; M E Murray; R Rademakers; O A Ross; Z K Wszolek; J E Parisi; D S Knopman; R C Petersen; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2017-03-08       Impact factor: 8.090

3.  Case of a Man with Hemichorea and Behavioral Changes: "A Red Herring".

Authors:  Galit Kleiner; Stephen A Ryan; Juan Bilbao; Julia Keith; Ekaterina Rogaeva; Sandra E Black; Anthony E Lang; Mario Masellis
Journal:  Mov Disord Clin Pract       Date:  2022-03-30

4.  Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis.

Authors:  Tiziana Petrozziello; Evan A Bordt; Alexandra N Mills; Spencer E Kim; Ellen Sapp; Benjamin A Devlin; Abigail A Obeng-Marnu; Sali M K Farhan; Ana C Amaral; Simon Dujardin; Patrick M Dooley; Christopher Henstridge; Derek H Oakley; Andreas Neueder; Bradley T Hyman; Tara L Spires-Jones; Staci D Bilbo; Khashayar Vakili; Merit E Cudkowicz; James D Berry; Marian DiFiglia; M Catarina Silva; Stephen J Haggarty; Ghazaleh Sadri-Vakili
Journal:  Mol Neurobiol       Date:  2021-11-10       Impact factor: 5.682

5.  Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.

Authors:  Andy J Liu; Jessica E Chang; Georges Naasan; Adam L Boxer; Bruce L Miller; Salvatore Spina
Journal:  Neurocase       Date:  2020-02-23       Impact factor: 0.881

Review 6.  Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review.

Authors:  Alexander J Moszczynski; Matthew A Hintermayer; Michael J Strong
Journal:  Front Neurosci       Date:  2018-04-20       Impact factor: 4.677

7.  Globular Glial Tauopathy Type I Presenting as Atypical Progressive Aphasia, With Comorbid Limbic-Predominant Age-Related TDP-43 Encephalopathy.

Authors:  Robert Rusina; Zsolt Csefalvay; Gabor G Kovacs; Jiri Keller; Alena Javurkova; Radoslav Matej
Journal:  Front Aging Neurosci       Date:  2019-12-11       Impact factor: 5.750

Review 8.  Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies.

Authors:  Vera I Wiersma; Jeroen J M Hoozemans; Wiep Scheper
Journal:  Acta Neuropathol Commun       Date:  2020-09-03       Impact factor: 7.801

Review 9.  Alterations in Tau Metabolism in ALS and ALS-FTSD.

Authors:  Michael J Strong; Neil S Donison; Kathryn Volkening
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

10.  Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes.

Authors:  Ryoko Takeuchi; Mari Tada; Atsushi Shiga; Yasuko Toyoshima; Takuya Konno; Tomoe Sato; Hiroaki Nozaki; Taisuke Kato; Masao Horie; Hiroshi Shimizu; Hirohide Takebayashi; Osamu Onodera; Masatoyo Nishizawa; Akiyoshi Kakita; Hitoshi Takahashi
Journal:  Acta Neuropathol Commun       Date:  2016-06-23       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.